 | Up a level |
Moots, Robert J 
ORCID: 0000-0001-7019-6211, Curiale, Cinzia, Petersel, Danielle, Rolland, Catherine, Jones, Heather and Mysler, Eduardo
(2018)
Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review.
BIODRUGS, 32 (3).
pp. 193-199.
Fleischmann, Roy, Mysler, Eduardo, Hall, Stephen, Kivitz, Alan J, Moots, Robert J ORCID: 0000-0001-7019-6211, Luo, Zhen, DeMasi, Ryan, Soma, Koshika, Zhang, Richard, Takiya, Liza et al (show 6 more authors)
(2017)
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
LANCET, 390 (10093).
pp. 457-468.
Zhao, Sizheng ORCID: 0000-0002-3558-7353, Mysler, Eduardo and Moots, Robert J ORCID: 0000-0001-7019-6211
(2018)
Etanercept for the treatment of rheumatoid arthritis.
IMMUNOTHERAPY, 10 (6).
pp. 433-445.
Zhao, Sizheng ORCID: 0000-0002-3558-7353, Chadwick, Laura ORCID: 0000-0001-6246-9558, Mysler, Eduardo and Moots, Robert J ORCID: 0000-0001-7019-6211
(2018)
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis.
CURRENT RHEUMATOLOGY REPORTS, 20 (10).
57-.
Chadwick, Laura, Zhao, Sizheng ORCID: 0000-0002-3558-7353, Mysler, Eduardo and Moots, Robert J ORCID: 0000-0001-7019-6211
(2018)
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis.
CURRENT RHEUMATOLOGY REPORTS, 20 (12).
84-.
Moots, Robert ORCID: 0000-0001-7019-6211, Azevedo, Valderilio, Coindreau, Javier L, Dörner, Thomas, Mahgoub, Ehab, Mysler, Eduardo, Scheinberg, Morton and Marshall, Lisa
(2017)
Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician.
Current rheumatology reports, 19 (6).
37-.